Considerations for Continuing Semielective and Emergency Otolaryngological Procedures During the COVID-19 Pandemic.


Journal

Ear, nose, & throat journal
ISSN: 1942-7522
Titre abrégé: Ear Nose Throat J
Pays: United States
ID NLM: 7701817

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 8 9 2020
medline: 29 12 2020
entrez: 7 9 2020
Statut: ppublish

Résumé

During the COVID-19 pandemic, worldwide over 600,000 human beings died due to the cause of the disease. In order to deescalate the transmission rate and to avoid crush loading the countries medical health systems social distancing, face masks, and lockdowns have been considered essential by the majority of governments. Whereas some countries have highly reduced or completely stopped otorhinolaryngological procedures, other countries have continued selected surgeries. The objective of this study was to analyze procedures and outcomes of continuing semielective and emergency surgeries during the COVID-19 pandemic. Retrospective analysis of n = 750 patients who received semi-elective or emergency surgery between March 26 and June 16, 2020, in the Otolaryngology Department of the Friedrich-Alexander-University of Erlangen-Nürnberg. All patients were screened for COVID symptoms and swabbed for SARS-CoV-2 prior to surgery. Of the n = 750 patients, n = 699 patients received semielective surgery and n = 51 emergency surgery. For 27 patients, the swab result could not be awaited due to a life-threatening condition. In these cases, surgery was performed in full protective equipment. No patient was tested positive during or after the surgery (follow-up 45 to 127 days). No member of the medical personnel showed symptoms or was tested positive after contact with patients. Due to the continuation of surgeries, patients' lives were saved and improvement of long-term quality-of-life and outcomes is anticipated. Continuing selected otorhinolaryngological surgeries is crucial for patients' health, survival, and long-time quality of life, yet, the protection of the medical personnel has to be granted.

Identifiants

pubmed: 32894699
doi: 10.1177/0145561320952506
pmc: PMC7477481
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-25

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Int Forum Allergy Rhinol. 2020 Jul;10(7):798-805
pubmed: 32243678
N Engl J Med. 2020 Jul 30;383(5):494-496
pubmed: 32492294
N Engl J Med. 2020 Aug 6;383(6):e38
pubmed: 32502334
Int Forum Allergy Rhinol. 2020 Oct;10(10):1186-1188
pubmed: 32558288
JAMA Otolaryngol Head Neck Surg. 2020 Jun 1;146(6):517-518
pubmed: 32232426
Can J Anaesth. 2020 Jul;67(7):902-904
pubmed: 32246431
J Card Surg. 2020 Jun;35(6):1345-1347
pubmed: 32419177
Ear Hear. 2014 Jul-Aug;35(4):396-409
pubmed: 24557003
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
HNO. 2017 Sep;65(9):758-765
pubmed: 28819872
Int J Infect Dis. 2020 May;94:107-109
pubmed: 32315809
Neurosurgery. 2020 Jul 1;87(1):E66-E67
pubmed: 32293678
Otolaryngol Head Neck Surg. 2020 Sep;163(3):465-470
pubmed: 32452739

Auteurs

Sarina K Mueller (SK)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Maximilian Traxdorf (M)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Konstantinos Mantsopoulos (K)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Antoniu-Oreste Gostian (AO)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Matti Sievert (M)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Michael Koch (M)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Matthias J Huebner (MJ)

Intensive Care Medicine/Department of Pediatric Cardiology, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Heinrich Iro (H)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, 9171Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH